CFTR and cystic fibrosis: These data provided on triple combination of CFTR modulators therapy are higher than those achieved on double combination (lumacaftor/ivacaftor or tezacaftor/ivacaftor) in Danish patients with CF followed for the same period of use (VO2peak 1.07 mL/min/kg, maximal workload change 14.2W) [18].